International aid cuts
The UK is shirking its moral duty to global health and development and putting scientific research in jeopardy by slashing £4bn from the international aid budget, scientists have criticised. Read the C&I Magazine news story.
Beyond biologics bottlenecks
Novel biologics provide access to targeted treatments for some of our most pressing medical conditions and meet the needs of an ageing global population. Biologics promise fewer side effects and the first steps towards personalised medicine, but the field is still in its infancy.
Biology without limits
The pharmaceutical sector can trace its roots to the isolation of natural small molecules with biological activity. It was this that drove synthetic organic chemistry and led to the development of a new industry.
Organic chemistry
Organic chemistry article written by G. Richard Stephenson from the University of East Anglia, UK for July 2021.
Nature’s sunscreens
Could compounds from coral and seaweed provide an environmentally friendly and safer alternative to current sunscreens? Emma Davies reports. Read the feature article in C&I magazine.
Ocean action
Our ocean is under threat. Multiple impacts, ranging from the consequences of climate change – increasing sea surface temperatures, ocean acidification, sea level rise and deoxygenation – to poor management practises, damaging gear and overfishing has led to more than a third of known marine species threatened with extinction.
Stereoselective fungal enzyme
An enzyme to control the stereochemistry of an anticancer compound could improve drug development and manufacture, US researchers say. Read the C&I news article.
Vanishing, wireless pacemaker
A temporary, implantable pacemaker has been developed that is fully absorbed into the body.
Antibiotic resistance probe
Over a decade ago, a patient in New Delhi, India, fell ill with a strain of bacteria discovered to contain a new genetic element – New Delhi metallo-β-lactamase (NDM) – that chops up antibiotics.